Value of Citrullinemia on Intestinal Function Evaluation in Short Bowel Syndrome

Authors

  • Beatriz Pinto Costa de Almeida Clínica Universitária de Cirurgia III da Faculdade de Medicina da Universidade de Coimbra e Serviço de Cirurgia III dos Hospitais da Universidade de Coimbra, E.P.E., Portugal
  • Marco Serôdio Serviço de Cirurgia III dos Hospitais da Universidade de Coimbra, E.P.E., Portugal
  • Marta Simões Centro de Neurociências e Biologia Celular da Universidade de Coimbra, Portugal
  • Carla Veríssimo Centro de Neurociências e Biologia Celular da Universidade de Coimbra, Portugal
  • Manuela Grazina Faculdade de Medicina da Universidade de Coimbra e Centro de Neurociências e Biologia Celular da Universidade de Coimbra, Portugal
  • F. Castro Sousa Clínica Universitária de Cirurgia III da Faculdade de Medicina da Universidade de Coimbra e Serviço de Cirurgia III dos Hospitais da Universidade de Coimbra, E.P.E., Portugal

Abstract

Introduction: Several studies suggest that citrullinemia may represent an objective and reproducible parameter of the enterocyte mass and function.

Objectives: To study the value of citrullinemia in intestinal function evaluation of short bowel syndrome.

Material and methods: A case-control study, including 11 patients with short bowel syndrome subsequent to massive enterectomy and 11 healthy controls, was undertaken. Plasma levels of amino acids were determined by ion exchange chromatography.

Results: In the first group, six patients presented a type III syndrome, five were in post-adaptation phase and nine were nutritionally autonomous; mean length of residual gut was 87,5±48,2 (30-190) cm. Citrullinemia in short bowel syndrome patients was inferior (28,6±11,3 versus 32,2±6,6; n.s.) and lower than 24 μmol/L in 45,5% of the cases (versus 9,1%; p=0,056; sensitivity=46%; specificity=91%; accuracy=68%). Citrullinemia correlated significantly with time of evolution (Pearson’s coefficient=70,2%; p=0,016) but wasn’t related with nutritional and body composition parameters; it was lower in cases with intestinal failure (17±8,5 versus 31,1±10,5 μmol/L; n.s.) and type I syndrome (25,3±4,9 versus 28±12 μmol/L; n.s.).

Conclusion: Present series suggests that citrullinemia, although susceptible to clinical and laboratorial interferences, may be useful in definition of prognosis and monitorization of short bowel syndrome.

Keywords: Citrullinemia, intestinal function, short bowel syndrome, ornithinemia 

Downloads

Download data is not yet available.

Published

2012-03-30

Issue

Section

Original Papers

Most read articles by the same author(s)